Loading patent…
AssigneeYasutoshi Muto
InventorsYasutoshi Muto, Hisataka Moriwaki, Mitsuo Ninomiya, Sadashi Adachi, Akiko Saito, Takeshi Takasaki, Takuji Tanaka, Kaito Tsurumi, Masataka Okuno, Eiichi Tomita, Toshiyuki Nakamura, Takao Kojima
Estimating the term…
The invention provides an anticarcinogenic drug composition which effectively inhibits the recurrence of hepatocellular carcinoma (the occurrence of second primary tumor), the occurrence of hepatocellular carcinoma in high risk groups with chronic hepatitis and liver cirrhosis, the occurrence of cervical carcinoma intraepitheliale, lung adenocarcinoma, lung squamous cell carcinoma, mammary tumor, and the like and is highly safe. The anticarcinogenic drug composition contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof.
A method for preventing the recurrence of hepatocellular carcinoma or the occurrence of hepatocellular carcinoma in a patient with chronic hepatitis or liver cirrhosis comprising administering to a patient an effective amount of a medicant comprising 3, 7, 11, 15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof.
A method for inducing apoptosis in hepatocellular carcinoma cells comprising administering to said cells an effective amount of 3, 7, 11, 15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof.
Dependencies are inferred from the claim text.